Eating Disorders News

The FDA has accepted Sunovion Pharmaceuticals’ New Drug Application for dasotraline, a novel dopamine and norepinephrine reuptake inhibitor, for the treatment of patients with moderate-to-severe binge eating disorder, according to a press release.

Massachusetts General Hospital has been named the number one hospital for psychiatric care in America for 2019 to 2020, according to the U.S. News & World Report.

Results from a genome-wide association study published in Nature Genetics implicated metabo-psychiatric origins of anorexia nervosa, supporting the reconceptualization of the disorder as both metabolic and psychiatric.

Although the incidence of eating disorders was relatively low compared with some other mental disorders in Wales, patients with eating disorders had a higher burden of morbidity, other mental health problems and mortality, according to study findings.

Youths who reported they were teased or ridiculed about their weight increased their BMI by 33% more each year compared with a similar group who reported they had not been teased, according to findings published in Pediatric Obesity.

Women who had an eating disorder at any point before childbirth were more likely to experience depressive symptoms during pregnancy and up to 18 years after giving birth, study findings published in British Journal of Psychiatry revealed.

Nearly one-quarter of children with autism spectrum disorder have pica — an eating disorder involving the eating of nonfood items — according to research presented at the CDC’s Epidemic Intelligence Service Conference.

A Danish nationwide birth cohort study showed that the incidence rates of any mental disorder, substance use disorders, depression and anxiety disorders increased substantially by adolescence.

Compared with placebo, participants with binge eating disorder demonstrated comparable clinical characteristics and responses to dose-optimized lisdexamfetamine bimesylate across age and gender subgroups, according to findings published in Journal of Clinical Psychiatry.

Adult outpatients with anorexia nervosa who received olanzapine gained more weight each month on average than those who received placebo, study findings revealed.